A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden

A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden

<p>Abstract</p> <p>Background</p> <p>Prostate-specific antigen (PSA) is widely used to detect prostate cancer. The low positive predictive value of elevated PSA results in large numbers of unnecessary prostate biopsies. We set out to determine whether a multivariable mo...

Full description

Bibliographic Details
Main Authors: Scardino Peter T, Pettersson Kim, Becker Charlotte, Pihl Carl-Gustav, Aus Gunnar, Cronin Angel M, Vickers Andrew J, Hugosson Jonas, Lilja Hans
Format: Article
Language:English
Published: BMC 2008-07-01
Series:BMC Medicine
Online Access:http://www.biomedcentral.com/1741-7015/6/19

Internet

http://www.biomedcentral.com/1741-7015/6/19

Similar Items